期刊文献+

依那普利与缬沙坦联合应用对慢性心力衰竭(CCHF)患者胰岛素抵抗的影响研究 被引量:4

下载PDF
导出
摘要 目的:分析应用缬沙坦与依那普利治疗慢性心力衰竭患者的临床疗效。方法:选取92例患有慢性心力衰竭的患者病例,将其分为对照组和治疗组各46例。对照组采用依那普利进行治疗,治疗组采用缬沙坦与依那普利联合进行治疗。结果:治疗组慢性心力衰竭症状改善效果明显优于对照组;治疗前后FINS、HOMA-IR水平的改善幅度明显大于对照组;心力衰竭症状复发率明显低于对照组;两组均未有任何药物不良反应。结论:应用缬沙坦与依那普利联合治疗慢性心力衰竭疗效显著。
出处 《亚太传统医药》 2013年第1期149-150,共2页 Asia-Pacific Traditional Medicine
  • 相关文献

参考文献3

二级参考文献20

  • 1MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure; Metoprolo CR/XL randomized intervention trial in congestive heart failure(MERIT-HF) [J].Lancet, 1999,353 (9169) : 2001.
  • 2Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled release metoprolol on total mortality,hospitalizations, and well-being in patients with heart failure. The Metoprolol CR/XL randomized intervention trial in congestive heart failure(MERIT-HF) [J]. JAMA, 2000,283 :1295.
  • 3Eric J, Eichhorn MD, Michael R, et al. Practical guidlines for initiation of beta-adrenergic blockade in patients with chronic heart failure[J]. Am J Cardiol, 1997, 70 : 794.
  • 4Esler M, Kaye D, Lambert G, et al. Adrenergic nervous system in heart failure[J]. Am J Cardiol, 1997,80 : 7.
  • 5Bristow MR. Mechanism of action of beta-blocking agents in heart failure[J]. Am J Cardiol, 1997,80 : 26.
  • 6Colucci W. Molecular and cellular mechanisms of myocardial failure[J]. Am J Cardiol, 1997,80 : 15.
  • 7Urata H,Healy B,Stewart RW,et al.Angiotensin Ⅱ forming pathways in normal and failing human hearts[J].Circ Res,1990,66:883
  • 8Campbell DJ,Kladis A,Valentijn AJ.Effects of losartan on angiotensin and bradykinin peptides and converting enzyme[J].J Cardiovasc Pharmacol,1997,80:158A
  • 9Weber KT,Sun Y,Tyagi SC,et al.Collagen network of the myocardial:function,structural,remodeling and regulatory mechanisms[J].J Cell Cardiol,1994,26(3):279
  • 10Sun Y,John Zhang JQ,Zhang J,et al.Cardiac remodeling by fibrous tissue after infarction in rats[J].J Lab Clin Med,2000,135(4):316

共引文献2145

同被引文献47

  • 1戴闺柱.2005年美国慢性收缩性心力衰竭治疗指南浅析[J].中华心血管病杂志,2005,33(12):1065-1066. 被引量:64
  • 2杨青茹.盐酸贝那普利对原发性高血压左室舒张功能及血清脑钠肽浓度的影响[J].东南大学学报(医学版),2007,26(1):52-54. 被引量:4
  • 3郭静萱,李海燕.慢性心力衰竭的诊治进展[J].中国实用内科杂志,2007,27(1):11-13. 被引量:159
  • 4Du Q, Wu J,Wang H, et al. Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoanti- bodies against angiotensin lI type 1 receptor[J]. BMC Cardiovasc Disord, 2013,13:94.
  • 5Marampon F, Gravina GL,Scarsella L,et al. Angi inhibition counteracts angiotensin 1]-mediated endothelial cell dysfunc- tion by modulating the p38/SirT1 axis[J]. J Hypertens,2013,31 (10): 1972-1983.
  • 6Mohanty IR ,Arya DS, Dinda A, et al. Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against isehemic reperfusion- induced cardiac toxicity[J]. Environ Toxieol Pharmacol,2013,35 (2): 207 -217.
  • 7Bitkin EC, Boyraz M, Taskin N, et al. Effects of ACE inhibitors on insulin resistance and lipid profile in children with metabolic syndrome[J]. J Clin Res Pediatr Endocrinol, 2013,5 (3) : 164-169.
  • 8Mavrakanas TA, Gariani K, Martin PY. Mineralocorticoid receptor blockadein addition to angiotensin converting enzyme inhibitor or angiotensin ]I receptor blocker treatment:an emerging paradigm in diabetic nephropathy: a systematic review[J]. Eur J Intern Med, 2014,25 (2) : 173-176.
  • 9Touyz RM. Molecular and cellular mechanisms in vacular injury in hyper- tension:role of angiotensin H [J]. Curt Opin Nephrol Hypertens, 2005,14 (2) : 125-131.
  • 10黄桂芝,蓝宝琼.舒张功能不全心衰10例临床分析[J].海南医学,2008,19(1):58-58. 被引量:1

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部